HomeCompareLEVIX vs ABBV

LEVIX vs ABBV: Dividend Comparison 2026

LEVIX yields 0.38% · ABBV yields 3.67%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ABBV wins by $19.7K in total portfolio value
10 years
LEVIX
LEVIX
● Live price
0.38%
Share price
$12.25
Annual div
$0.05
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.2K
Annual income
$38.48
Full LEVIX calculator →
ABBV
AbbVie Inc.
● Live price
3.67%
Share price
$168.90
Annual div
$6.20
5Y div CAGR
8.9%
Payout ratio
58%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.9K
Annual income
$1,154.43
Full ABBV calculator →

Portfolio growth — LEVIX vs ABBV

📍 ABBV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLEVIXABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LEVIX + ABBV cover 4 of 12 monthsgood coverage

Jan
ABBV
Feb
Mar
Apr
ABBV
May
Jun
Jul
ABBV
Aug
Sep
Oct
ABBV
Nov
Dec
LEVIX pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LEVIX
Annual income on $10K today (after 15% tax)
$31.92/yr
After 10yr DRIP, annual income (after tax)
$32.71/yr
ABBV
Annual income on $10K today (after 15% tax)
$312.02/yr
After 10yr DRIP, annual income (after tax)
$981.27/yr
At 15% tax rate, ABBV beats the other by $948.56/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LEVIX + ABBV for your $10,000?

LEVIX: 50%ABBV: 50%
100% ABBV50/50100% LEVIX
Portfolio after 10yr
$30.1K
Annual income
$596.46/yr
Blended yield
1.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

LEVIX
No analyst data
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+51.7% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LEVIX buys
0
ABBV buys
0
No recent congressional trades found for LEVIX or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLEVIXABBV
Forward yield0.38%3.67%
Annual dividend / share$0.05$6.20
Payout ratio50%58%
1-year div growth0%4.7%
5-year div CAGR0%8.9%
Portfolio after 10y$20.2K$39.9K
Annual income after 10y$38.48$1,154.43
Total dividends collected$381.00$7.2K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LEVIX vs ABBV ($10,000, DRIP)

YearLEVIX PortfolioLEVIX Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$10,738$37.55$11,520$399.75$782.00ABBV
2$11,527$37.68$13,261$450.98$1.7KABBV
3$12,372$37.81$15,255$508.41$2.9KABBV
4$13,275$37.92$17,536$572.74$4.3KABBV
5$14,243$38.03$20,145$644.78$5.9KABBV
6$15,278$38.13$23,126$725.38$7.8KABBV
7$16,386$38.23$26,532$815.52$10.1KABBV
8$17,571$38.32$30,420$916.26$12.8KABBV
9$18,839$38.40$34,855$1,028.80$16.0KABBV
10$20,197$38.48$39,914$1,154.43$19.7KABBV

LEVIX vs ABBV: Complete Analysis 2026

LEVIXStock

The Portfolio invests primarily in equity securities, principally common stocks, of U.S. companies of any market capitalization. The Portfolio has a concentrated portfolio of investments, typically investing in 15 to 35 companies with market capitalizations generally greater than $350 million. The Portfolio seeks to outperform broad-based securities market indices, such as the S&P 500® Index, the Russell 1000® Index and the Russell 3000® Index. Under normal circumstances, the Portfolio invests at least 80% of its assets in equity securities of U.S. companies. The fund is non-diversified.

Full LEVIX Calculator →

ABBVHealthcare

AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.

Full ABBV Calculator →
📬

Get this LEVIX vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LEVIX vs SCHDLEVIX vs JEPILEVIX vs OLEVIX vs KOLEVIX vs MAINLEVIX vs JNJLEVIX vs MRKLEVIX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.